ProHealth | The 2nd International Symposium For CFS/ME Overview By Rosamund Vallings ... ProHealth Other interventions include rituximab, cytokine blockers and GcMAF. [Dr. Peterson's assertion that a drug can be a 'biomarker' refers to the idea of segregating patients according to their response to treatment, and then digging into their physiology ... |
